Dermoscopy Augmented Histology Trial, a Randomized Controlled Trial

Pathologists provide the current gold standard in skin lesion diagnostics, most often primarily based on the interpretation of histological slides. Still, it has been suggested that pathologists' diagnostic accuracy and confidence could be improved if they gained access to additional clinical information and in-vivo clinical and dermoscopic images of melanocytic tumors. This study examines the effect of digital training for pathologists in interpreting dermoscopic and clinical skin tumor images. This study aims to evaluate the impact of dermoscopy training on pathologists' assessment of melanoma-suspected skin lesions. Data collection of DAHT cases: Department of plastic surgery, Herlev hospital, year 2020-2021, DAHT platform: Made in 2021-2023 by Melatech, Consensus agreement: Four dermatopathologists assess all DAHT cases, year 2023-2024 Enrollment of pathologists: Randomization and assessment DAHT cases, year 2026.

NCT Number	NCT05004792
Lead Sponsor	Herlev Hospital
Conditions	Melanoma, Pigmented Lesions
Enrollment	258 participants
Start Date	2026-08-13
Primary Completion	2026-12-13 (estimated)
Study Completion	2027-12-13 (estimated)
Updated on ClinicalTrials.gov	2026-06-25